VIVA BIOTECH (01873) issues 8.58 million share purchase rights.
VIA Life Sciences (01873) announced that, in accordance with its share purchase plan adopted on April 14, 2019, the company granted share purchase rights to several eligible participants on December 2, 2025, to subscribe for a total of 8.58 million ordinary shares of the company.
VIVA BIOTECH (01873) announced that the company has granted stock options to a number of eligible participants on December 2, 2025, in accordance with the stock option plan adopted on April 14, 2019, to subscribe for a total of 8.58 million ordinary shares of the company.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


